华大基因：第三季度归母净利润亏损2716.52万元

Core Viewpoint - BGI Genomics reported a revenue of 1.042 billion yuan for Q3 2025, marking a year-on-year increase of 9.19%, while the net profit attributable to shareholders was a loss of 27.1652 million yuan, compared to a loss of 143 million yuan in the same period last year [1] Financial Performance - For the first three quarters, the company achieved a revenue of 2.674 billion yuan, reflecting a year-on-year decline of 5.39% [1] - The net profit attributable to shareholders for the first three quarters was a loss of 21.387 million yuan, compared to a loss of 124 million yuan in the same period last year [1] - The basic earnings per share for Q3 2025 was a loss of 0.0653 yuan, while for the first three quarters, it was a loss of 0.0514 yuan [1]